These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32090361)

  • 21. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
    Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
    Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch.
    Sun H; Liang L; Li Y; Feng C; Li L; Zhang Y; He S; Pei D; Guo Y; Zheng H
    Sci Rep; 2016 Aug; 6():30903. PubMed ID: 27481483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal.
    Zhang J; Nuebel E; Daley GQ; Koehler CM; Teitell MA
    Cell Stem Cell; 2012 Nov; 11(5):589-95. PubMed ID: 23122286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of Odd-Skipped Related 2, a Novel Regulator of Epithelial-Mesenchymal Transition, Enables Efficient Somatic Cell Reprogramming.
    Anh LPH; Nishimura K; Kuno A; Linh NT; Kato T; Ohtaka M; Nakanishi M; Sugihara E; Sato TA; Hayashi Y; Fukuda A; Hisatake K
    Stem Cells; 2022 Apr; 40(4):397-410. PubMed ID: 35385105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly Efficient Derivation of Pluripotent Stem Cells from Mouse Preimplantation and Postimplantation Embryos in Serum-Free Conditions.
    De Los Angeles A; Okamura D; Wu J
    Methods Mol Biol; 2019; 2005():29-36. PubMed ID: 31175643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial cadherin regulates transition between the naïve and primed pluripotent states in mouse embryonic stem cells.
    Sharaireh AM; Fitzpatrick LM; Ward CM; McKay TR; Unwin RD
    Stem Cells; 2020 Oct; 38(10):1292-1306. PubMed ID: 32621788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Reprogramming, Autophagy, and Reactive Oxygen Species Are Necessary for Primordial Germ Cell Reprogramming into Pluripotency.
    Sainz de la Maza D; Moratilla A; Aparicio V; Lorca C; Alcaina Y; Martín D; De Miguel MP
    Oxid Med Cell Longev; 2017; 2017():4745252. PubMed ID: 28757909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency.
    Zhang H; Gayen S; Xiong J; Zhou B; Shanmugam AK; Sun Y; Karatas H; Liu L; Rao RC; Wang S; Nesvizhskii AI; Kalantry S; Dou Y
    Cell Stem Cell; 2016 Apr; 18(4):481-94. PubMed ID: 26996599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell metabolism in tissue development and aging.
    Shyh-Chang N; Daley GQ; Cantley LC
    Development; 2013 Jun; 140(12):2535-47. PubMed ID: 23715547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcineurin-NFAT Signaling Controls Somatic Cell Reprogramming in a Stage-Dependent Manner.
    Sun M; Liao B; Tao Y; Chen H; Xiao F; Gu J; Gao S; Jin Y
    J Cell Physiol; 2016 May; 231(5):1151-62. PubMed ID: 26448199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct Molecular Trajectories Converge to Induce Naive Pluripotency.
    Stuart HT; Stirparo GG; Lohoff T; Bates LE; Kinoshita M; Lim CY; Sousa EJ; Maskalenka K; Radzisheuskaya A; Malcolm AA; Alves MRP; Lloyd RL; Nestorowa S; Humphreys P; Mansfield W; Reik W; Bertone P; Nichols J; Göttgens B; Silva JCR
    Cell Stem Cell; 2019 Sep; 25(3):388-406.e8. PubMed ID: 31422912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response and Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming.
    Peñalosa-Ruiz G; Bousgouni V; Gerlach JP; Waarlo S; van de Ven JV; Veenstra TE; Silva JCR; van Heeringen SJ; Bakal C; Mulder KW; Veenstra GJC
    Stem Cell Reports; 2019 Apr; 12(4):743-756. PubMed ID: 30880078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAS Regulates the Transition from Naive to Primed Pluripotent Stem Cells.
    Altshuler A; Verbuk M; Bhattacharya S; Abramovich I; Haklai R; Hanna JH; Kloog Y; Gottlieb E; Shalom-Feuerstein R
    Stem Cell Reports; 2018 Mar; 10(3):1088-1101. PubMed ID: 29456180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent insights into the naïve state of human pluripotency and its applications.
    Dong C; Fischer LA; Theunissen TW
    Exp Cell Res; 2019 Dec; 385(1):111645. PubMed ID: 31585117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stepwise pluripotency transitions in mouse stem cells.
    Endoh M; Niwa H
    EMBO Rep; 2022 Sep; 23(9):e55010. PubMed ID: 35903955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells.
    Kovacic B; Rosner M; Schipany K; Ionce L; Hengstschläger M
    Eur J Clin Invest; 2015 Apr; 45(4):415-22. PubMed ID: 25646864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pluripotency Deconstructed.
    Kinoshita M; Smith A
    Dev Growth Differ; 2018 Jan; 60(1):44-52. PubMed ID: 29359419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation.
    Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H
    Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
    Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
    PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
    Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
    Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.